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In recent years  the question of immunity following antityphoid 
vaccination,  the  typhoid  carrier  problem,  and  the  possibilities  of 
chemotherapy have  restimulated investigation of  experimental ty- 
phoid infections in the lower animals. 
A review of the present status of infection in animals below the apes is givet~ 
by Hailer and Ungermann (I).  In the case  of the rabbit the original observa- 
tion  dates  back  to  1891, when  Blachst6in  and  Welch  (2)  noted  that,  after 
intravenous inoculation of  colon  and  typhoid  bacilli,  rabbits  may  develop  a 
lesion of the gall bladder which may persist for several months.  Apparently no 
further work was  done with this lesion at that time, but,  in the  last few years, 
infection of the organs of the rabbit and especially of the gall bladder have been 
used for various purposes by Doerr  (3), Koch (4), Chiarolanza (5), Conradi (6), 
Hailer  and  Rimpau  (7),  Hailer  and  Ungermann  (8),  Hailer  and  Wolf  (9), 
Uhlenhuth  and  Messersehmidt  (IO),  Morgan  (IZ),  Johnston  (,12), Gay  and 
Claypole  (13), and Cummins and Cumming (14). 
It has been shown that typhoid bacilli  can be isolated  from the 
organs for some time after injection, but that the gall bladder lesion 
is the most persistent source.  After intravenous injection, the gall 
bladder  apparently becomes infected by  way  of  the  blood  stream 
as well as  from the bile.  It has also been shown that intravenous 
inoculation  does  not  regularly  result  in  producing  gall  bladder 
lesions and most of the experimenters in chemotherapy have given 
up this method for the direct inoculation of the gall bladder.  The 
intravenous method of  infection, however, more nearly  resembles 
the natural method and has advantages for some purposes. 
In this paper the  following subjects are considered:  (I)  patho- 
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genicity of  a  living sensitized vaccine,  (2)  pathogenicity of  first 
transplant  from  a  living sensitized vaccine,  (3)  the  regular  pro- 
duction of lesions, (4)  the gall bladder lesion as a test of immunity, 
(5)  the curative effects of vaccines, and (6) the practical bearing of 
experimental  work.  Altogether,  ninety-seven  animals  have  been 
used and forty gall bladder lesions have been observed. 
PATHOGENICITY  OF A  LIVING  SENSITIZED  VACCINE. 
The  writer's  attention  was  first  attracted  to  the  gall  bladder 
lesion as a means of determining whether or not a  living sensitized 
vaccine is pathogenic.  As is well known, Metchnikoff and Besredka 
(I5),  as  a  result of their  work with experimental typhoid in the 
chimpanzee, devised a living sensitized vaccine for protection.  This 
vaccine has been criticized as likely to produce carriers,  if not the 
disease  itself.  Metchnikoff and  Besredka's  own  observations  on 
the  possibility of  producing carriers  in  apes  and  man  have  been 
negative.  My  own  experience  with  rabbits  has  been  the  same. 
Through  the  kindness  of  Prof. Besredka  I  secured  some  of  his 
vaccine which was  living at  the time of use,  as  evidenced by the 
growth  from  the  vaccine  of  a  typical  typhoid  organism.  The 
"vaccine was given intravenously to nine animals, and subcutaneously 
¢o  one  animal,  in  doses  of  two  to  six  cubic  centimeters.  Two 
animals were sacrificed on the day following intravenous injection, 
and cultures made  from the bile  were sterile.  The other animals 
were examined after one month; cultures from the bile were nega- 
tive in all cases for typhoid bacilli, and no macroscopic evidence of 
disease was  found.  It may, therefore, be concluded that intraven- 
ous injection of this vaccine does not produce gall bladder lesions in 
the rabbit, and by inference that no danger exists of producing car- 
riers  in man by subcutaneous injection. 
PATHOGENICITY  OF  THE  FIRST  TRANSFER  OF  A  LIVING  SENSITIZED 
VACCINE. 
While the original vaccine is apparently harmless, the first trans- 
plant  on  agar  is  pathogenic, as  is  indicated by  the  following ex- 
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Nov.  18,  1913.  A  large  agar  slant  was  inoculated  with  vaccine  and,  after 
twenty-four hours, the growth was  collected in 2o c.c. of  salt solution and 6  e.e. 
were given intravenously to a  rabbit weighing 3,ooo  gin.  On Dec. 23, the animal 
was  killed and a  well marked  lesion of  the gall bladder  was  found and the bile 
contained a  pure culture of  typhoid bacilli. 
Hence while the vaccine itself is apparently safe, it has possibili- 
ties of harm in case it became accidentally deposited on media suit- 
able  for multiplication.  This  is  a  point  of some practical impor- 
tance in the military service in which ampules may unavoidably be 
broken in transportation  or in camp.  According to the results of 
this experiment, any water or food accidentally contaminated with 
this  vaccine might transmit the disease to non-immunes.  It may, 
therefore, be  stated that  a  living  sensitized vaccine is  not entirely 
safe to handle, as is  a  killed vaccine  (16). 
ATTEMPTS  TO PRODUCE  GALL  BLADDER  LESIONS  REGULARLY  BY 
INTRAVENOUS  INJECTION. 
While the above work was in progress,  Gay and Claypole  (I3) 
published a paper in which the authors stated that regular infections 
had been produced by intravenous injection of growths from rabbit 
blood agar.  In order to try the effect of this procedure, the strain 
from the living vaccine was carried on rabbit blood agar and passed 
through lesions in five animals,  as is  seen in table  I.  The growth 
on a blood agar slant was suspended in twenty cubic centimeters of 
salt solution, and two cubic centimeters, or one half the fatal dose, 
were given intravenously and the animals were examined after one 
month. 
TABLE I. 
Attempts to Produce  Gall Bladder  Lesions  with Transfers from Besredka's 
Vaccine on Blood Agar. 
No. of passage.  No. of animals,  Positive,  Negative. 
I  I  I  O 
'~  6  I  5 
3  3  I  2 
4  I  I  o 
5  5  I  4 
x6  5  IZ 
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It will be seen that with this strain cultivation on blood agar had 
no effect in maintaining pathogenicity,  nor did passage through four 
animals in series.  In the fifth transfer  only one animal out of five 
became  infected.  In  this  connection  it  should  be  noted  that  the 
strain  Gay and Claypole  worked with  was  recently  isolated. 
In order to determine  the effect  of the age  of the culture several 
strains  were  tried  with  the  following  results.  One  half  the  fatal 
dose  of  an  agar  or  bouillon  growth  was  given  intravenously  and 
the animals were examined after one month  (table II). 
TABLE  II. 
Attempts  to  Produce  Gall  Bladder  Lesions  with  Various  Strains  Given 
Intravenously. 
Strain. 
Clark 
Fuguet 
Andrews 
Clark 
Rawlings 
Dorset 
Besredka 
Age of strain. 
I  mo, 
I  lrlo. 
I  mo. 
3  mos, 
14  yrs. 
I5  yrs. 
? 
No. of animals.  Positive, 
8  6 
2  I 
4  o 
4  o 
6  o 
5  I 
I6  5 
Negative, 
2 
I 
4 
4 
6 
4 
II 
45  13  32 
f  (28.8%) 
The conclusion to be drawn from these experiments is that  freshly 
isolated  strains  produce  lesions  in  a  higher  percentage  than  old 
strains,  but even  freshly isolated strains cannot always be depended 
on to produce lesions by the  intravenous  method.  This  conclusion 
agrees  with  that  of  nearly  every  investigator  and  has  been  em- 
phasized  by  Uhlenhuth  and  Messerschmidt,  and  Hailer  and  Un- 
germann.  As stated  above, these authors  have given up the  intra- 
venous  method  for  the  more  certain  method  of  direct  inoculation 
of the gall bladder. 
THE  GALL  BLADDER  LESION  AS  A  TEST  OF  IMMUNITY. 
Gay and  Claypole  also  state  that  the  gall  bladder  lesion  can  be 
used as a  test of immunity conferred by vaccines.  Evidently such 
a  test  in  an  animal  would  be  of  great  value  in  many  ways,  but 
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purpose.  The  instantaneous  introduction  of  a  large  number  of 
bacilli directly into the circulation seems to break down any artificial 
immunity  produced  by  vaccines.  Uhlenhuth  and  Messerschmidt 
(IO)  have  been unable  to  protect  animals  from  infection  with  the 
Pfeiffer-KoUe  vaccine,  although  immune  bodies  were  present  in 
large  quantities.  The  infecting  dose  was  given  directly  into  the 
gall  bladder.  My  experience  has  been  the  same  with  the  Army 
vaccine,  using the  intravenous  route.  Although  it  is  impossible to 
carry on  well  controlled  experiments  with  the  intravenous  method 
when  the  results  are  so  uncertain,  the  positive  results  have  some 
significance. 
Ten rabbits were used.  Six were vaccinated  with  IOO million  subcutaneously, 
followed  at weekly  intervals  by two doses  of 2o0 million,  intravenously.  Four 
were  vaccinated  similarly  with  doses  of 5oo and  i,ooo million.  Ten  days  after 
the last vaccination,  all  were given an intravenous  injection  of about one  half 
the  fatal dose of Besredka's organism.  After one month,  two animals of each 
set  showed  definite infections of the gall bladder.  The percentage of infections 
was 4o, while  the percentage of infections among controls  (16)  was 31. 
Hence no protective  effect of vaccination  could  be demonstrated 
in the  rabbit.  As the  protective effect of the  same vaccine in man 
is  well known,  this  result  simply means  that  the  conditions  of  the 
experiment  in  the  rabbit  are  not  comparable  with  those  in  natural 
infections in man. 
ATTEMPTS  TO CURE THE GALL BLADDER LESION  BY VACCINES. 
Johnston  (12)  states that vaccines may have some curative effect 
on  the  lesion  of  the  gall  bladder.  Uhlenhuth  and  Messerschmidt 
(I0)  were  unable  to  obtain such  a  result,  and  Cummins  and  Cum- 
ming  (14)  also  state  that  vaccine  treatment  did  not  influence  the 
finding  of  living bacilli  in  the  liver  and  gall bladder.  I  have  also 
been unable to demonstrate  any curative effect of vaccines. 
Two rabbits were given I e.e. of a broth culture of Clark strain intravenously 
on  Apr. 27,  1914.  Plating  of  feces  was  positive to  typhoid bacilli  on  May  15, 
1914.  Both animals were then given subcutaneously  four doses  of vaccine,  one 
dose every five days,  running  from IO to 80  million.  One  week  after the last 
dose the animals were autopsied,  and  the bile in  both cases  yielded  a  pure cul- 
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Two  human  carriers  who  have  been  studied  in  this  laboratory 
and reported by Leary (17)  were treated over several months with 
autogenous and stock vaccines and failed to show any marked dim- 
inution in the excretion of bacteria.  Both  cases were operated on 
and  the  gall  bladders,  containing  pure  cultures  of  the  organism, 
were  removed.  Excretion  of  typhoid  bacilli  in  the  stools  ceased 
permanently in nine days:  It is, of course, not claimed that removal 
of the gall bladder will cure all carriers, because we know that the 
bile passages  and intestinal mucosa may be affected in some cases. 
But our experience with the curative effect of vaccines has not been 
encouraging either clinically or experimentally. 
PRACTICAL  BEARING  OF  EXPERIMENTAL  WORK. 
In  this  laboratory  our  chief  interest  in  experimental  infections 
has naturally centered in their possible relation to immunity follow- 
ing vaccination.  As is  well known, the present army vaccine was 
devised in  1908 by Major F.  F.  Russell  of the Medical Corps,  on 
the basis of German and English experience.  During the last five 
years we have manufactured over  1,7oo,ooo  cubic centimeters for 
the  Army,  Navy,  National  Guard,  and  other  departments  of  the 
Government,  and  over  25o,ooo  men  have  been  immunized.  The 
results of the use of this product have been fully detailed by Major 
Russell  (18)  in a number of contributions to our knowledge of this 
subject.  It  is  only necessary here to  emphasize the  fact that  the 
conditions of its use have been those of extensive experimentation. 
The subjects  are exposed to  infection in many parts  of the world 
and are under close observation for several years at least.  The re- 
sults have exceeded all expectations, and, on the basis of English and 
American experience, we can now  give a  definite answer to  some 
of the problems of immunity in man. 
In the first place it is clear that the conclusions reached by Metch- 
nikoff and  Besredka  from  their  work  on  chimpanzees  cannot  be 
accepted for man.  These authors found that a whole killed vaccine 
did not protect their animals.  But they used tremendous infecting 
doses,--the contents  of a  whole Kolle  flask.  On  the other hand, 
they were able to protect with a  living sensitized vaccine.  But,  as Henry  J. Nichols.  579 
has  already been  pointed  out,  this  vaccine  is  not  entirely  safe to 
handle and its use could certainly not be made compulsory.  Hence, 
if we folloWed these experimental results strictly, we would not be 
using  any vaccine and  the  splendid  results  would  have  been lost. 
Inasmuch as the final object of all experimental work on this  sub- 
ject is the protection of man,  it would be  a  reductio  ad  absurdum 
to give up the goal, once reached, because we cannot duplicate the 
conditions in animals. 
In the same way the gall bladder lesion in the rabbit  fails as an 
index of  immunity from vaccination in  relation  to  man.  For  an 
attack on  the typhoid carrier problem this  lesion seems ideal,  and 
it  may possibly  serve  in  advancing the  chemotherapy of  typhoid 
fever.  It  certainly  gives  an  admirable  experimental  opportunity 
for testing methods of isolating typhoid bacilli from the feces.  But 
the  claim  of  Gay and  Claypole,  that  this  lesion  can be  used  as  a 
test of immunity from vaccination, seems unfounded, and for the 
same reason as in the case of the chimpanzees.  Human conditions: 
cannot be duplicated and immunization  which is  known to  protect~ 
man is not effective under these different conditions. 
While the subject was developing, many products were proposed; 
the whole killed vaccine, autolysates, residues, fractions, etc.  When 
it became evident that a  whole killed vaccine had some advantages, 
other  questions  arose.  What  strain  should  be  used?  Should  it 
be virulent or avirulent ?  Should it be fresh or old ?  Should sev- 
eral strains be used?  Should they be sensitized?  A  great deal of 
work done with immune bodies has  given no convincing answer to 
these questions.  As a result of actual trial we can say that a whole 
vaccine killed by heat at  53 °  C.  and preserved with 0.25  per cent. 
tricresol  protects human  beings  from  typhoid  fever;  that  an  old 
avirulent strain is effective; that a  single str~,in  is  effective against 
.typhoid in all parts of the world  (19) ; that doses of 500 and I,OOO 
million  at  intervals  of  seven  or  ten  days  are  effective; that  two 
doses protect for two years and that three doses protect for a longer 
period not yet exactly de'termined; that the vaccine keeps its immu- 
nizing properties for at least four months. 
Gay and Claypole say that "Empiricism rather than experimenta- 
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trary,  experimentation has  marked every step of  the evolution of 
our present vaccine since the first paper on the subject in  I896, by 
Pfeiffer and Kolle  (20).  The  only peculiarity has  been  that  the 
teachings of clinical experience have been given some weight; and 
that experimental results have been taken for just what they were 
worth and no more.  No claim is made that  the Army vaccine is 
the summum  bonum  in antityphoid vaccines.  Improvements may 
come,  but  before  our  results  are  improved  upon,  they  must  be 
equalled.  And they must be equalled, not in a  few chimpanzees or 
rabbits, but in large numbers of human beings under observation for 
several  years. 
At  present  the  subjects  which  give  concern  are,  naturally,  the 
length of immunity and the keeping qualities of the vaccine.  Evi- 
dence on these points is  accumulating from actual experience, and 
we know of no other safe method of reaching conclusions on these 
points. 
SUMMARY. 
I.  Besredka's living sensitized vaccine, given intravenously, does 
not produce a typhoid lesion of the gall bladder in the rabbit. 
2.  The  first  transplant  of  this  vaccine  is  capable  of  producing 
~his lesion.  Hence this vaccine is not entirely safe to handle. 
3-  Regular infections of the gall bladder have not been produced 
by  carrying  a  known pathogenic strain  on  rabbit  blood  agar,  by 
successive passage through animals,  or  by the use of  freshly iso- 
lated strains. 
4.  No evidence could be demonstrated in the rabbit of the immun- 
ity produced in man by vaccination with a  whole killed vaccine. 
5.  Vaccine treatment did not cure the gall bladder lesion. 
6.  With  the  present  methods  of  producing  infections  in  the 
chimpanzee and the rabbit,  neither of these animals is suitable  for 
deciding the  problems  of  the  immunization of  man  by  vaccines. 
These problems must be settled, as some of them already have been 
settled, by actual experience with large numbers of men kept under 
close observation. Henry  J.  Nichols.  581 
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